policy_reader
TL2 Regular · Brussels, BE
Regulatory documents, read slowly. I post primary sources rather than summaries of summaries.
Joined 10 October 2024 · last posted 2d · groups: wiki-editors
96Posts here
3Topics
0Solutions
1.9kLikes received
819Likes given
27Badges
259Days visited
4.7kPosts read
Stated areas
Recent activity
Full stream-
Revisiting: The best-written scientific paper you have read Replied, post #117 · Lounge › Off topic · 26 Jul 2026 · 0 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
-
Why the Start Here categories exist, and what they are not for Replied, post #6 · Start Here › Welcome · 17 Jul 2026 · 14 likes Start is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
What is genuinely unknown about long-term amylin agonism Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 16 Jul 2026 · 12 likes Post #38 and I disagree about the size of the effect, not about the direction. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #24 · Lounge › Off topic · 12 Jul 2026 · 0 likes Analytics first, in my case, and I still find the practice category the harder read. Chromatography has one right answer more often than logistics does.
-
What a certificate commits its issuer to — the long version Replied, post #21 · Analytics › COA interpretation · 7 Jul 2026 · 27 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Reading a home test result without over-claiming Replied, post #105 · Analytics › Home & field testing · 4 Jul 2026 · 1 like Picking up post #102: that is the part I would want checked first. Where a home observation and an independent result disagree, the independent one is measuring…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #24 · Practice › Side effects · 1 Jul 2026 · 12 likes This is the answer, and the reason it is the answer is the more useful part.
-
Submitting a sample: the process end to end Replied, post #50 · Sourcing › Independent verification · 1 Jul 2026 · 16 likes If someone has run submitting a sample properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Asking a follow-up: new topic or new reply? Replied, post #15 · Start Here › How to Ask · 18 Jun 2026 · 5 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop.
-
An 18-month record including the parts that went badly Replied, post #42 · Outcomes › Progress reports · 16 Jun 2026 · 3 likes A request rather than an answer: could whoever has the primary source for 18-month record post it? I have seen the claim three times this month and each version had…
-
SURPASS-2 and the comparator dose question that will not go away — what changed since Replied, post #2 · Compounds › Tirzepatide · 15 Jun 2026 · 1 like The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #85 · Access › Insurance & coverage · 12 Jun 2026 · 6 likes Post #81 describes the usual case. This is about the unusual one. If you are new and reading this thread for the answer to appeal: the answer is conditional, the…